Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-23

FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (ONESOURCE SPECIALTY PHARMA LIMITED)

View source ↗

Summary

FDA approved an original application for mycophenolate mofetil, a generic immunosuppressant used to prevent organ transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

ORIG AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)